BianoScience GmbH

BianoScience GmbH is a privately owned biotech company that operates as a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO), specialising in oligonucleotide synthesis and peptide production. Founded in 2011 as a spin-off from the Friedrich-Schiller-University of Jena, Germany, BianoScience has focused on developing high-purity, high-quality nucleotide-based molecules. The company has established a therapeutic RNA prodrug platform known as chiRNA, which is designed for selective activation in diseased tissue, targeting anticancer and antiviral therapies. BianoScience supports collaborative development or licensing of its innovative technologies for specific applications, demonstrating its commitment to advancing biotechnological solutions in the pharmaceutical industry.

Services include:
- Contract manufacturing of oligonucleotides
- Contract development and manufacturing services (CDMO)
- High-quality synthesis of nucleotide-based molecules
- Custom synthesis of peptides
- Labelling and characterisation services
- In vitro and tissue analytics
- cGMP oligonucleotide production

BianoScience GmbH is dedicated to providing exceptional biotechnological services to the academic and biotech community, leveraging its extensive portfolio of processes and technologies. For more information, please visit bianoscience.com.